RADIANT phase 2 shows once-daily remlifanserin eases Alzheimer’s psychosis symptoms with placebo-like safety, advancing pivotal trials.
|Slideshows|July 13, 2020
Understanding Dementia-Related Psychosis
Author(s)Heidi Anne Duerr, MPH
According to some estimates, nearly 2.3 million people in the US suffer from dementia-related psychosis. The Gerontological Society of America’s diagnostic and treatment considerations help shed light on this complicated condition.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
The Adolescent Brain and Schizophrenia: What Research Reveals About Pruning, Dopamine, and Myelin
2
Searching for a New TMS Target in Schizophrenia, With Andrew Pines, MD
3
Using Psychotherapy for the Prevention of Relapse in Schizophrenia
4
Exploring a Misuse of Neuroscience: How Biology Has Been Used to Remove Responsibility in Youth
5